Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;17(7):1121-1133.
doi: 10.1002/alz.12291. Epub 2021 Mar 4.

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia

Kirsty E McAleese  1 , Sean J Colloby  1 , Alan J Thomas  1 , Safa Al-Sarraj  2 , Olaf Ansorge  3 , James Neal  4 , Federico Roncaroli  5 , Seth Love  6 , Paul T Francis  2   7 , Johannes Attems  1
Affiliations

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia

Kirsty E McAleese et al. Alzheimers Dement. 2021 Jul.

Abstract

Introduction: The aged brain frequently exhibits multiple pathologies, rather than a single hallmark pathology (pure pathology [PurP]), ranging from low/intermediate levels of additional pathology (LowP) to mixed severe pathology (mixed SevP). We investigated the frequency of PurP, LowP, and mixed SevP, and the impact of additional LowP on cognition.

Methods: Data came from 670 cases from the Brains for Dementia research program. Cases were categorized into PurP, mixed SevP, or a main disease with additional LowP; 508 cases had a clinical dementia rating.

Results: 69.9% of cases had LowP, 22.7% had PurP, and 7.5% had mixed SevP. Additional LowP increased the likelihood of having mild dementia versus mild cognitive impairment (MCI) by almost 20-fold (odds ratio = 19.5).

Discussion: Most aged individuals have multiple brain pathologies. The presence of one additional LowP can significantly worsen cognitive decline, increasing the risk of transitioning from MCI to dementia 20-fold. Multimorbidity should be considered in dementia research and clinical studies.

Keywords: cerebral multimorbidity; clinicopathological study; cognitive impairment; concomitant pathology; dementia; hyperphosphorylated tau; multiple pathologies; neuropathology.

PubMed Disclaimer

References

REFERENCES

    1. Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm. 2015;122:505-521.
    1. Rahimi J, Kovacs GG. Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther. 2014;6:82.
    1. Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, et al. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol. 2015;129:729-748.
    1. Cognitive NGMRC, FaA Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet. 2001;357:169-175.
    1. Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci. 2007;257:80-87.

Publication types

Substances

LinkOut - more resources